-
UTILITY GENERATION FOR SANFILIPPO SYNDROME TYPE A (MPS IIIA) USING HEALTH-STATE VIGNETTES
Aug 11, 2026, 17:16 PM -
METABOLOMIC SIGNATURES AND THERAPEUTIC DRUG MONITORING IN SCHIZOPHRENIA: A SCOPING REVIEW OF ANTIPSYCHOTIC TREATMENT OUTCOMES
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF PAFOLACIANINE-GUIDED INTRAOPERATIVE MOLECULAR IMAGING WITH STANDARD OF CARE VERSUS STANDARD OF CARE ALONE FOR THE IDENTIFICATION OF OCCULT SYNCHRONOUS LESIONS DURING LUNG CANCER SURGICAL RESECTIONS IN US
Aug 11, 2026, 17:16 PM -
HOW DO REGULATORY AND HTA BODIES ADDRESS CLINICAL TRIAL REPRESENTATIVENESS AND INCLUSIVITY: A GREY LITERATURE REVIEW FROM READI
Aug 11, 2026, 17:16 PM -
PREFERENCE ELICITATION USING TTO AND DCE: WHO FINDS WHICH TASKS MORE DIFFICULT?
Aug 11, 2026, 17:16 PM -
STRENGTHENING INFECTION PREVENTION AND CONTROL CAPACITY TO REDUCE SECONDARY BACTERIAL INFECTIONS AMONG ORTHOPOX VIRUS-MONKEYPOX HOSPITALIZED PATIENTS IN UGANDA
Aug 11, 2026, 17:16 PM -
AUTOMATED HTA DRAFT DOSSIER GENERATION AND QUALITY ASSURANCE BASED ON AN AI AGENTIC WORKFLOW WITH ITERATIVE FACT-CHECKING AND QUALITY GATE MECHANISM
Aug 11, 2026, 17:16 PM -
THE INCLUSION OF NON-MANDATORY CLINICAL OUTCOME ASSESSMENTS IN HEALTH TECHNOLOGY ASSESSMENT REVIEWS IN ENGLAND, FRANCE, AND GERMANY: IMPLICATIONS FOR BENEFIT RATINGS, PRICING, AND SALES
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF RAPID MULTIPLEX PCR PANEL FOR SEPSIS DIAGNOSIS IN ICU PATIENTS: VERTICALLY PRIVATE PLAN IN BRAZIL
Aug 11, 2026, 17:16 PM -
DEVELOPMENT OF THE DUTCH VALUE SET FOR THE PROMIS PREFERENCE SCORE (PROPR)
Aug 11, 2026, 17:16 PM -
SAME GENERATION, DIFFERENT STATE: REGIONAL DISPARITIES IN SICK LEAVE ACROSS BABY BOOMERS, GEN-X, MILLENNIALS, AND GEN-Z IN GERMANY
Aug 11, 2026, 17:16 PM -
CHALLENGE OF ATMP REIMBURSEMENT AND PATIENT ACCESS IN A CHANGING UK LANDSCAPE
Aug 11, 2026, 17:16 PM -
DIVERSITY IN HEALTH TECHNOLOGY ASSESSMENT (HTA) PRACTICES ACROSS LATIN AMERICA: A CROSS-COUNTRY REVIEW OF DECISION FRAMEWORKS, EVIDENCE REQUIREMENTS AND ACCESS LINKAGES
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT OF BIOLOGIC THERAPIES FOR INFLAMMATORY BOWEL DISEASE IN SAUDI ARABIA: A 5-YEAR ANALYSIS SUPPORTING FORMULARY MANAGEMENT
Aug 11, 2026, 17:16 PM -
EARLY IMPACT OF MOST FAVOURED NATION (MFN) POLICY ON REIMBURSEMENT DECISIONS, LAUNCH ACTIVITY, AND MARKET ACCESS IN SWEDEN
Aug 11, 2026, 17:16 PM -
WILL THE EU JOINT CLINICAL ASSESSMENT RESHAPE GLOBAL LAUNCH SEQUENCING FOR ONCOLOGY MEDICINES AND ATMPS?
Aug 11, 2026, 17:16 PM -
ASSESSING THE FEASIBILITY OF A GERMAN ELECTRONIC HEPATOLOGY NETWORK DATABASE AS A REAL-WORLD DATA SOURCE FOR STEATOTIC LIVER DISEASE RESEARCH
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF RIMEGEPANT VERSUS STANDARD OF CARE FOR PREVENTIVE TREATMENT OF EPISODIC MIGRAINE IN NORWAY: THE IMPACT OF PRODUCTIVITY GAINS
Aug 11, 2026, 17:16 PM -
WHEN SURVIVAL CURVES MISLEAD INTERPRETATION: NON-IDENTIFIABILITY OF TIME-TO-EVENT EVIDENCE IN CROSS-STUDY HEOR COMPARISONS
Aug 11, 2026, 17:16 PM -
ASSESSMENT OF REAL-WORLD TREATMENT PATTERNS AND SURVIVAL OUTCOMES OF SMALL CELL LUNG CANCER PATIENTS IN ENGLAND UTILISING THE ENGLISH CANCER REGISTRY DATA
Aug 11, 2026, 17:16 PM
